- advertising -
Generic selectors
Exact match only
Search in title
Search in content
Post Type Selectors
Filter by category
News
Experts' opinions
Sponsored content
Formulation
Ingredients
Media kit
The magazine
Software
Management
Make-up
We tested for you
Packaging
Fragrances
Industrial processes
Regulations
CSR

Anjac Health & Beauty strengthens its position in North America and its pharmaceutical activities

Anjac Health & Beauty (Anjac) has announced the acquisition of Pillar5 Pharma (Pillar5), a leading CDMO specialized in the production of sterile ophthalmic solutions and niche solid forms (tablets, capsules, etc.). This operation confirms Anjac's international expansion and extends its healthcare offering with a new ophthalmic range to serve local and international brands and laboratories. This is Anjac's second major operation in 2022, following the merger with Apollo Healthcare last January.

Pillar5, CDMO a key player in the sterile ophthalmology market in North America.

A Canadian company, Pillar5 is one of North America's leading CDMOs for the production of sterile ophthalmic solutions and solid forms (tablets, capsules, etc.) Pillar5 is a pioneer and the only CDMO to offer innovative ophthalmic solutions on the North American market, namely preservative-free sterile multidoses.

An independent company since 2009, Pillar5, based in Arnprior, Ontario, offers a complete range of services, from product formulation and manufacture to packaging customization and technical services. With a diversified and loyal customer portfolio, Pillar5 supports major pharmaceutical companies as well as ophthalmic care specialists.

The company has 150 employees and sales of $CAD 50 million.

A unique entrepreneurial dynamism

With Pillar5, the Anjac group signs its 9ᵉ acquisition in five years, and sees its overall sales reach almost 650 million euros following this operation, doubling in the space of three years. Each new acquisition represents an opportunity for the Anjac Group to extend its range of services in specific fields, while leveraging their complementarities. The Anjac Group now comprises 14 expert companies, with 22 R&D and manufacturing sites.

"We are delighted with this strategic acquisition, which will enable us to expand into a key new segment, the ophthalmic market, and more specifically into the high value-added innovation of preservative-free, multi-dose sterile ophthalmic solutions.explains Aurélien Chaufour, President of the Anjac Group.

"We are delighted to be joining a family-owned industrial group that will support us in our ambitious expansion plans. We have already identified synergies, notably with international customers who can be supported by Pillar5 and other companies in the Anjac group".says Dwight Gorham, President and CEO of Pillar5.

External resources

Sponsored content

site-industries-cosmetiques A concentrated individual in a lab coat examining a small jar containing a pink substance, a pioneering cosmetic innovation using natural ingredients in Brittany.

Cosmetics innovation comes naturally in Bretagne

In north-west France, Bretagne has always been a seawardlooking region with its 2,730km coastline - the longest in the country.

Related articles

Our last issue

Listen to us!

Newsletter

en_USEnglish